Dashboard
Manage Tickers

OGNOrganon & Co.

NYSE organon.com


$ 20.44 $ 0.19 (0.94 %)    

Friday, 10-May-2024 15:59:51 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ 1.04 (0.24 %)
DIA $ 395.04 $ 1.18 (0.3 %)
SPY $ 520.76 $ 0.67 (0.13 %)
TLT $ 90.14 $ -0.51 (-0.56 %)
GLD $ 218.73 $ 1.76 (0.81 %)
$ 20.42
$ 20.37
$ 0.00 x 0
$ 0.00 x 0
$ 20.30 - $ 20.75
$ 10.53 - $ 22.54
1,333,778
na
5.28B
$ 0.82
$ 5.04
TBD
na
na ($ 0.05)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-09-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-27-2023 12-31-2022 10-K
7 11-04-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-06-2022 03-31-2022 10-Q
10 03-21-2022 12-31-2021 10-K
11 11-12-2021 09-30-2021 10-Q
12 08-16-2021 06-30-2021 10-Q
13 06-21-2021 03-31-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-with-over-5-dividend-yields
Wall Street's Most Accurate Analysts' View...
05/10/2024 12:01:24

reported-earlier-organon-prices-1b-dual-series-senior-notes-500m-6750-secured-500m-7875-unsecured-both-due-2034
Reported Earlier, Organon Prices $1B Dual ...
05/08/2024 08:02:01

The Companies intend to use the net proceeds from the sale of the Notes to repay a portion of their borrowings under the Credit...

organon-announces-proposed-10b-senior-notes-offering
Organon Announces Proposed $1.0B Senior No...
05/07/2024 11:59:49

Organon (NYSE:OGN) ("Organon"), a global healthcare company with a focus on women's health, announced today that it...

goldman-sachs-maintains-neutral-on-organon-raises-price-target-to-20
Goldman Sachs Maintains Neutral on Organon...
05/06/2024 15:27:04

Goldman Sachs analyst Chris Shibutani maintains Organon (NYSE:OGN) with a Neutral and raises the price target from $18 to $20.

goldman-sachs-maintains-neutral-on-organon-raises-price-target-to-20
Goldman Sachs Maintains Neutral on Organon...
05/03/2024 15:59:13

Goldman Sachs analyst Chris Shibutani maintains Organon (NYSE:OGN) with a Neutral and raises the price target from $18 to $20.

organon-beats-on-q1-womens-health-leads-the-charge
Organon Beats On Q1, Women's Health Leads ...
05/02/2024 17:58:23

Organon reported 5% increase in Q1 2024 revenue of $1.622 billion, beating consensus. EPS of $1.22 and dividend of $0.28 declared.

organon-reaffirms-2024-revenues-guidance-of-62b-65b-versus-consensus-of-637b
Organon Reaffirms 2024 Revenues Guidance O...
05/02/2024 11:34:39

organon-q1-2024-adj-eps-122-beats-093-estimate-sales-1622b-beat-1563b-estimate
Organon Q1 2024 Adj EPS $1.22 Beats $0.93 ...
05/02/2024 11:32:43

Organon (NYSE:OGN) reported quarterly earnings of $1.22 per share which beat the analyst consensus estimate of $0.93 by 31.18 p...

piper-sandler-maintains-overweight-on-organon-raises-price-target-to-24
Piper Sandler Maintains Overweight on Orga...
04/29/2024 11:44:11

Piper Sandler analyst David Amsellem maintains Organon (NYSE:OGN) with a Overweight and raises the price target from $22 to ...

wall-streets-most-accurate-analysts-views-on-3-health-care-stocks-delivering-high-dividend-yields
Wall Street's Most Accurate Analysts' View...
03/13/2024 12:24:39

During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often com...

5-value-stocks-in-the-healthcare-sector
5 Value Stocks In The Healthcare Sector
03/04/2024 14:44:45

new-york-attorney-general-urges-fda-action-on-widely-used-asthma-drugs-concerns-over-pediatric-safety
New York Attorney General Urges FDA Action...
02/26/2024 15:56:30

The Attorney General of New York, Letitia James, has called on the FDA to address safety risks associated with the widely used ...

first-lady-jill-biden-unveils-100m-in-federal-funding-to-support-rd---watch-out-for-these-women-health-stocks
First Lady Jill Biden Unveils $100M In Fed...
02/21/2024 17:24:52

Jill Biden announces $100 million in federal funding for women's health research, addressing underfunding and lack of aware...

thursday-is-your-last-chance-to-buy-organon-before-the-dividend-payout
Thursday Is Your Last Chance To Buy Organo...
02/20/2024 14:45:29

organon-announces-hadlima-adalimumab-bwwd-has-been-exclusively-selected-by-us-department-of-veterans-affairs-replacing-humira-on-its-national-formulary
Organon Announces Hadlima (Adalimumab-bwwd...
02/20/2024 13:04:53

HADLIMA is an FDA-approved biosimilar to HUMIRA for the treatment of specific autoimmune or autoinflammatory conditions such as...

why-is-women-health-focused-organon-stock-trading-higher-on-thursday
Why Is Women Health-Focused Organon Stock ...
02/15/2024 20:39:25

Organon exceeds Q4 2023 revenue expectations, reaching $1.6 billion. Women's Health thrives with 7% revenue increase, drive...

why-herbalife-shares-are-trading-lower-by-around-36-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why Herbalife Shares Are Trading Lower By ...
02/15/2024 18:20:19

Shares of Herbalife Ltd. (NYSE: HLF) fell sharply in today’s session following weak quarterly earnings.

reliance-steel--aluminum-posts-upbeat-earnings-joins-jfrog-applovin-shake-shack-and-other-big-stocks-moving-higher-on-thursday
Reliance Steel & Aluminum Posts Upbeat Ear...
02/15/2024 15:23:41

U.S. stocks were mostly higher, with the Dow Jones index gaining more than 150 points on Wednesday.

organon-forecasts-2024-full-year-revenues-of-62b-65b-versus-consensus-of-640b-with-adjusted-ebitda-margin-of-310-330
Organon Forecasts 2024 Full Year Revenues ...
02/15/2024 12:38:31

organon-q4-adjusted-eps-088-beats-083-estimate-sales-160b-beat-155b-estimate
Organon Q4 Adjusted EPS $0.88 Beats $0.83 ...
02/15/2024 12:32:22

Organon (NYSE:OGN) reported quarterly earnings of $0.88 per share which beat the analyst consensus estimate of $0.83 by 6.02 pe...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION